{
  "retracted": false,
  "timestamp": 1538352000000,
  "updates": [
    {
      "timestamp": 1560379249323,
      "identifier": {
        "doi": "10.1016/j.jhep.2018.07.015"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.jhep.2017.06.026"
  },
  "journal": "Journal of Hepatology",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies” [J hepatol 67 (2017) 999–1008]"
}
